BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10586037)

  • 1. The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes.
    Loyer V; Fontaine P; Pion S; Hétu F; Roy DC; Perreault C
    J Immunol; 1999 Dec; 163(12):6462-7. PubMed ID: 10586037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.
    Pion S; Fontaine P; Desaulniers M; Jutras J; Filep JG; Perreault C
    Eur J Immunol; 1997 Feb; 27(2):421-30. PubMed ID: 9045913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of APC in the selection of immunodominant T cell epitopes.
    Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
    J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes.
    Wolpert EZ; Grufman P; Sandberg JK; Tegnesjö A; Kärre K
    J Immunol; 1998 Nov; 161(9):4499-505. PubMed ID: 9794374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTL induction by cross-priming is restricted to immunodominant epitopes.
    Pavelic V; Matter MS; Mumprecht S; Breyer I; Ochsenbein AF
    Eur J Immunol; 2009 Mar; 39(3):704-16. PubMed ID: 19189311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Gag cytolytic T lymphocytes specific for an alternative translational reading frame-derived epitope and resistance versus susceptibility to retrovirus-induced murine AIDS in F(1) mice.
    Mayrand SM; Healy PA; Torbett BE; Green WR
    Virology; 2000 Jul; 272(2):438-49. PubMed ID: 10873788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
    Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
    J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo.
    Agadjanyan MG; Kim JJ; Trivedi N; Wilson DM; Monzavi-Karbassi B; Morrison LD; Nottingham LK; Dentchev T; Tsai A; Dang K; Chalian AA; Maldonado MA; Williams WV; Weiner DB
    J Immunol; 1999 Mar; 162(6):3417-27. PubMed ID: 10092797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy.
    Chamoto K; Wakita D; Narita Y; Zhang Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T
    Cancer Res; 2006 Feb; 66(3):1809-17. PubMed ID: 16452242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular and functional characterization of a dominant minor H antigen, H60.
    Malarkannan S; Shih PP; Eden PA; Horng T; Zuberi AR; Christianson G; Roopenian D; Shastri N
    J Immunol; 1998 Oct; 161(7):3501-9. PubMed ID: 9759870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-presenting cells and the selection of immunodominant epitopes.
    Blum JS; Ma C; Kovats S
    Crit Rev Immunol; 1997; 17(5-6):411-7. PubMed ID: 9419428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and immunogenetic analysis of an immunodominant peptide (B6dom1) encoded by the classical H7 minor histocompatibility locus.
    Eden PA; Christianson GJ; Fontaine P; Wettstein PJ; Perreault C; Roopenian DC
    J Immunol; 1999 Apr; 162(8):4502-10. PubMed ID: 10201988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced multiepitope-based vaccines elicit CD8+ cytotoxic T cells against both immunodominant and cryptic epitopes.
    Tine JA; Firat H; Payne A; Russo G; Davis SW; Tartaglia J; Lemonnier FA; Demoyen PL; Moingeon P
    Vaccine; 2005 Jan; 23(8):1085-91. PubMed ID: 15620483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edge: myelin basic protein-specific cytotoxic T cell tolerance is maintained in vivo by a single dominant epitope in H-2k mice.
    Huseby ES; Ohlén C; Goverman J
    J Immunol; 1999 Aug; 163(3):1115-8. PubMed ID: 10415003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cells.
    Dupont J; Latouche JB; Ma C; Sadelain M
    Cancer Res; 2005 Jun; 65(12):5417-27. PubMed ID: 15958591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope affinity for MHC class I determines helper requirement for CTL priming.
    Franco A; Tilly DA; Gramaglia I; Croft M; Cipolla L; Meldal M; Grey HM
    Nat Immunol; 2000 Aug; 1(2):145-50. PubMed ID: 11248807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-experienced CD4(+) T cells limit naïve T-cell priming in response to therapeutic vaccination in vivo.
    Schiering C; Guarnerio J; Basso V; Muzio L; Mondino A
    Cancer Res; 2010 Aug; 70(15):6161-70. PubMed ID: 20631073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen.
    Sigal LJ; Crotty S; Andino R; Rock KL
    Nature; 1999 Mar; 398(6722):77-80. PubMed ID: 10078533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RPE cells resist bystander killing by CTLs, but are highly susceptible to antigen-dependent CTL killing.
    Gregerson DS; Lew KL; McPherson SW; Heuss ND; Ferrington DA
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5385-94. PubMed ID: 17122128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.